Y-mAbs Therapeutics, Inc. (YMAB): Price and Financial Metrics


Y-mAbs Therapeutics, Inc. (YMAB)

Today's Latest Price: $32.80 USD

0.17 (-0.52%)

Updated Feb 18 8:00pm

Add YMAB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

YMAB Daily Price Range
YMAB 52-Week Price Range

YMAB Stock Price Chart More Charts


YMAB Price/Volume Stats

Current price $32.80 52-week high $36.29
Prev. close $32.97 52-week low $19.03
Day low $32.50 Volume 90,500
Day high $33.89 Avg. volume 173,206
50-day MA $32.60 Dividend yield N/A
200-day MA $27.23 Market Cap 1.30B

Y-mAbs Therapeutics, Inc. (YMAB) Company Bio


Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab for the treatment of pediatric patients with central nervous system/leptomeningeal metastases, desmoplastic small round cell tumors, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. The company has a license and research collaboration agreement with Memorial Sloan-Kettering Cancer Center. Y-mAbs Therapeutics, Inc. was founded in 2015 and is based in New York, New York.


YMAB Latest News Stream


Event/TimeNews Detail
Loading, please wait...

YMAB Latest Social Stream


Loading social stream, please wait...

View Full YMAB Social Stream

YMAB Price Returns

1-mo N/A
3-mo 13.57%
6-mo 27.28%
1-year 42.55%
3-year N/A
5-year N/A
YTD 4.96%
2019 53.64%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6145 seconds.